8305 — Allurefem Holding Income Statement
0.000.00%
Last trade - 00:00
- HK$39.90m
- HK$48.90m
- HK$143.41m
- 20
- 53
- 23
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 220 | 173 | 154 | 185 | 143 |
Cost of Revenue | |||||
Gross Profit | 30.3 | 22.8 | 17.1 | 22.5 | 7.86 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 216 | 175 | 196 | 208 | 172 |
Operating Profit | 4.49 | -1.07 | -41.4 | -23.5 | -28.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 3.19 | -2.82 | -43.1 | -25.4 | -30.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.26 | -2.29 | -42.6 | -24.6 | -30.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.26 | -2.29 | -42.6 | -24.6 | -30.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.26 | -2.29 | -42.6 | -24.6 | -30.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.003 | -0.008 | -0.027 | -0.019 | -0.027 |